Hologic EBITDA 2010-2024 | HOLX

Hologic EBITDA for the quarter ending September 30, 2024 was $0.316B, a 282.93% increase year-over-year.

  • Hologic 2024 EBITDA was 1.192B, a 20.15% increase from 2023.
  • Hologic 2023 EBITDA was 0.992B, a 52.09% decline from 2022.
  • Hologic 2022 EBITDA was 2.07B, a 28.29% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Hologic EBITDA 2010-2024 | HOLX

  • Hologic 2024 EBITDA was 1.192B, a 20.15% increase from 2023.
  • Hologic 2023 EBITDA was 0.992B, a 52.09% decline from 2022.
  • Hologic 2022 EBITDA was 2.07B, a 28.29% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$217.3B
Intuitive Surgical (ISRG)$204B
Alcon (ALC)$45.1B
Edwards Lifesciences (EW)$42B
IQVIA Holdings (IQV)$35.9B
IDEXX Laboratories (IDXX)$34.3B
DexCom (DXCM)$33.8B
Waters (WAT)$24B
STERIS (STE)$21.7B
SONOVA HOLDING (SONVY)$20.8B
Fresenius Medical Care AG KGaA (FMS)$14.6B
Globus Medical (GMED)$12.6B
Sysmex ADR (SSMXY)$12.2B
Penumbra (PEN)$10.4B
Masimo (MASI)$9.5B
Glaukos (GKOS)$8.8B
Teleflex (TFX)$8.4B
Integer Holdings (ITGR)$4.8B
Inari Medical (NARI)$4.7B
PROCEPT BioRobotics (PRCT)$3.8B
Veracyte (VCYT)$3.4B
LivaNova (LIVN)$2.8B
Nihon Kohden (NHNKY)$2.6B
Tandem Diabetes Care (TNDM)$2.4B
Elekta AB (EKTAY)$2.3B
TransMedics (TMDX)$2.2B
Integra LifeSciences Holdings (IART)$2B
Alphatec Holdings (ATEC)$1.7B
Artivion (AORT)$1.3B
RxSight (RXST)$1.3B